Bosco Anthony, Wiehler Shahina, Proud David
Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6872, Australia.
Airway Inflammation Research Group, Snyder Institute for Chronic Diseases, and the Department of Physiology & Pharmacology, University of Calgary Faculty of Medicine, Calgary, AB, Canada.
BMC Genomics. 2016 Jan 25;17:76. doi: 10.1186/s12864-016-2405-z.
Human rhinoviruses (HRV) cause the majority of colds and trigger exacerbations of chronic lower airway diseases. Airway epithelial cells are the primary site for HRV infection and replication, and the initiation of host inflammatory responses. At present, the molecular mechanisms that underpin HRV responses in airway epithelial cells are incompletely understood. The aim of this study was to employ microarray profiling, upstream regulator analysis, and siRNA mediated gene silencing to further our understanding of the role of interferon regulatory factor 7 (IRF7) in this response.
Primary human bronchial epithelial cells (HBE) where transfected with siRNA that targets IRF7 or a non-silencing control (all-star control) using Lipofectamine. The cells were allowed to recover, and then cultured in the presence or absence of HRV-16 for 24 h. Global patterns of gene expression were profiled on microarrays. A subset of genes identified in the microarray study were validated at the mRNA and/or protein level using real time RT-qPCR, ELISA, and western blots.
Hundreds of genes were upregulated in HBE during HRV infection. Pathways analysis demonstrated that these genes were mainly involved in type I and II interferon signaling, RIG-I/MDA5 signaling, antigen processing and presentation, and apoptosis. Upstream regulator analysis of these data suggested that IRF7 was a major molecular driver of this response. Knockdown of IRF7 reduced the HRV-driven upregulation of genes involved in antiviral responses (interferon signaling, Toll-like receptor signaling, NOD-like receptor signaling, RIG-I/MDA5 signaling), and increased the expression of genes that promote inflammation (e.g. CXCL5, IL-33, IL1RL1) and the response to oxidative stress. However, the majority of genes that were perturbed by HRV in HBE cells including those that are known to be regulated by IRF7 were insensitive to IRF7 knockdown. Upstream regulator analysis of the part of the response that was insensitive to IRF7 knockdown suggested it was driven by NF-κB, STAT1, STAT3, and IRF1.
Our findings demonstrate that IRF7 regulates the expression of genes involved in antiviral immunity, inflammation, and the response to oxidative stress during HRV infections in HBE cells, and also suggests that other transcription factors play a major role in this response.
人鼻病毒(HRV)引发大多数感冒,并引发慢性下呼吸道疾病的加重。气道上皮细胞是HRV感染、复制以及宿主炎症反应起始的主要部位。目前,气道上皮细胞中HRV反应的分子机制尚未完全明确。本研究的目的是利用微阵列分析、上游调节因子分析和小干扰RNA(siRNA)介导的基因沉默,进一步了解干扰素调节因子7(IRF7)在该反应中的作用。
使用脂质体转染试剂将靶向IRF7的siRNA或非沉默对照(全星对照)转染至原代人支气管上皮细胞(HBE)。使细胞恢复,然后在有或无HRV-16的情况下培养24小时。在微阵列上分析基因表达的整体模式。使用实时逆转录定量聚合酶链反应(RT-qPCR)、酶联免疫吸附测定(ELISA)和蛋白质免疫印迹法在mRNA和/或蛋白质水平对微阵列研究中鉴定的一部分基因进行验证。
HRV感染期间,HBE中有数百个基因上调。通路分析表明,这些基因主要参与I型和II型干扰素信号传导、视黄酸诱导基因I(RIG-I)/黑色素瘤分化相关基因5(MDA5)信号传导、抗原加工和呈递以及细胞凋亡。对这些数据的上游调节因子分析表明,IRF7是该反应的主要分子驱动因素。敲低IRF7可降低HRV驱动的抗病毒反应相关基因(干扰素信号传导、Toll样受体信号传导、NOD样受体信号传导、RIG-I/MDA5信号传导)的上调,并增加促进炎症的基因(如CXCL5、白细胞介素33、白细胞介素1受体样分子1)的表达以及对氧化应激的反应。然而,HRV在HBE细胞中干扰的大多数基因,包括已知受IRF7调节的基因,对IRF7敲低不敏感。对IRF7敲低不敏感的部分反应的上游调节因子分析表明,其由核因子κB(NF-κB)、信号转导和转录激活因子1(STAT1)、信号转导和转录激活因子3(STAT3)以及IRF1驱动。
我们的研究结果表明,IRF7在HBE细胞的HRV感染期间调节抗病毒免疫、炎症以及氧化应激反应相关基因的表达,并且还表明其他转录因子在该反应中起主要作用。